EUCR
Eucrates Biomedical Acquisition
EUCR | NASDAQ
Chart Builder DCF Calculator
$10.04
$0.00 (0.00%)
At close: Apr 26, 2023, 03:14 PM ET

Eucrates Biomedical Acquisition Income Statement

Income statement explained
Fiscal Year
Period Ending
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
– – –
– – –
– – –
-699K -743K 8.59K
701.13K 35.76K –
2.42M 3.82M 8.59K
5.54M 3.82M 8.59K
– 743.07K –
– – –
698.58K – 8.59K
698.58K 743.07K 8.59K
– – –
– – –
698.58K 743.07K 8.59K
-3.12M – –
2.98M 2.98M 13.46M
2.98M 13.46M 13.46M
1.86 1.28 0
1.86 0.28 0
-699K -743K 8.59K
-699K -743K –
– – 206.3K

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.